Literature DB >> 24316892

Subclinical atherosclerosis in ankylosing spondylitis: is there a role for inflammation?

Renato Leandro Mattar Valente, Jamil Mattar Valente, Gláucio Ricardo Werner de Castro, Adriana Fontes Zimmermann, Sonia Cristina de Magalhães Souza Fialho, Ivânio Alves Pereira.   

Abstract

OBJECTIVES: To evaluate the prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis (AS) in comparison to controls with similar cardiovascular risk factors.
METHODS: Forty-two consecutive patients with AS and 42 controls matched for age (43.3 ± 11.7 vs. 43.7 ± 11.3, P = 0.89), gender, smoking, diabetes mellitus and arterial hypertension were enrolled. Participants were excluded if a personal cardiovascular disease (CV) history was present. A questionnaire recording demographic data, medical and medication history was fulfilled. Blood pressure, abdominal circumference, height and weight were measured. Lipid profile was determined in a 12-hour fastened blood sample. Ultrasound analysis of the common carotid artery was performed by one blind observer. The distance between the lumen-intima interface and the leading edge of the media-adventitia interface (IMT) was measured and participants were also evaluated for the presence of plaques.
RESULTS: The comparative analysis of demographic and cardiovascular risk factors between AS patients and controls did not reveal statistically significant differences. Also, no significant differences between groups were observed for TC, HDL-C, T-C/HDL-C, LDL-C, triglycerides, or dyslipidemia frequency. IMT measures were not different in AS and controls (0.62 ± 0.09 vs. 0.61 ± 0.09, P = 0.39) as well as plaques frequencies (19% vs. 17%, P = 0.78).
CONCLUSIONS: Subclinical atherosclerosis assessed through carotid ultrasound imaging was not more prevalent in the AS group when compared to controls with similar cardiovascular risks. Our observations may imply that CV risk factors may have more influence on the CV system than AS itself. These findings should be confirmed in a larger population with a prospective study design.

Entities:  

Mesh:

Year:  2013        PMID: 24316892

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN: 0482-5004


  8 in total

1.  Comorbidities in Argentine patients with axial spondyloarthritis: Is nephrolithiasis associated with this disease?

Authors:  Fernando Sommerfleck; Emilce Schneeberger; Gustavo Citera
Journal:  Eur J Rheumatol       Date:  2018-06-22

2.  The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis.

Authors:  A Kucuk; A Uğur Uslu; A Icli; E Cure; S Arslan; K Turkmen; A Toker; M Kayrak
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

3.  Epicardial adipose tissue thickness in patients with ankylosing spondylitis.

Authors:  Hatice Resorlu; Ayla Akbal; Mustafa Resorlu; Ferhat Gokmen; Can Ates; Fatma Uysal; Gurhan Adam; Nilufer Aylanc; Muhammet Arslan; Besir Sahin İnceer
Journal:  Clin Rheumatol       Date:  2014-03-21       Impact factor: 2.980

Review 4.  The Role of MicroRNAS in Ankylosing Spondylitis.

Authors:  Zheng Li; Sunny H Wong; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Prevalence of Subclinical Carotid Atherosclerosis and Vitamin D Deficiency in Egyptian Ankylosing Spondylitis Patients.

Authors:  Dina Salem Fotoh; Dena Mamdouh Serag; Ismail Tawfeek Badr; Dalia Salah Saif
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

6.  Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts.

Authors:  Ana Maria Gherghe; Maxime Dougados; Bernard Combe; Robert Landewé; Carina Mihai; Francis Berenbaum; Xavier Mariette; Ron Wolterbeek; Désirée van der Heijde
Journal:  RMD Open       Date:  2015-09-14

7.  Evaluation of serum thiol/disulfide homeostasis in patients with ankylosing spondylitis by a novel method.

Authors:  Rabia Aydogan Baykara; Ayca Tuzcu; Ahmet Omma; Gunseli Karaca Acet; Erdal Dogan; Almila Aydin; Medine Cumhur Cure; Erkan Cure; Adem Kucuk; Ozcan Erel
Journal:  North Clin Istanb       Date:  2018-08-08

8.  The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitis

Authors:  Rabia Aydoğan Baykara; Adem Küçük; Ayça Tuzcu; Göksel Tuzcu; Erkan Cüre; Ali Uğur Uslu; Ahmet Omma
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.